970*90
768
468
mobile

Aurobindo Pharma to buy Apotex’s 5 European businesses

Franchise India Bureau
Franchise India Bureau Jul 16 2018 - 1 min read
Aurobindo Pharma to buy Apotex’s 5 European businesses
The acquisition is in line with Aurobindo’s strategy to strengthen its European business and to expand in Eastern Europe’s generics drug market.

Aurobindo Pharma Ltd has signed a pact to acquire the commercial operations and certain supporting infrastructure of Apotex International Inc. in five European countries for €74 million ($86.5 million).

The acquisition is in line with Aurobindo’s strategy to strengthen its European business and to expand in Eastern Europe’s generics drug market, the Indian drugmaker said in a stock-exchange filing.

The five countries are Poland, the Czech Republic, the Netherlands, Spain and Belgium.

The acquisition will diversify Aurobindo’s European product portfolio by adding over 200 generics and more than 80 over-the-counter (OTC) products that had total sales of €133 million in the year ended March 2018.

Aurobindo said closing of the transaction is conditional on the receipt of competition clearances for the transaction by the Dutch and Polish authorities. The deal is likely to be completed in three to six months’ time, it said.

Subscribe Newsletter
Submit your email address to receive the latest updates on news & host of opportunities
Entrepreneur Magazine

For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you

or Click here to Subscribe Online